EUDA Health Holdings Limited (EUDA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EUDA Health Holdings Limited (EUDA) has a cash flow conversion efficiency ratio of 0.163x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-607.71K) by net assets ($-3.73 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EUDA Health Holdings Limited - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how EUDA Health Holdings Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read EUDA Health Holdings Limited debt and liabilities for a breakdown of total debt and financial obligations.
EUDA Health Holdings Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EUDA Health Holdings Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cardiex Ltd
AU:CDX
|
-0.452x |
|
PT Jaya Bersama Indo Tbk
JK:DUCK
|
-0.035x |
|
Aqua Metals Inc
NASDAQ:AQMS
|
-0.176x |
|
PAKERS.Co.Ltd
KQ:065690
|
0.012x |
|
Inbest Prime III Inmuebles SOCIMI S.A.
MC:YINB3
|
N/A |
|
INVO Fertility, Inc.
NASDAQ:IVF
|
-0.304x |
|
Origin Agritech Ltd
NASDAQ:SEED
|
0.216x |
|
Indiana Resources Ltd
AU:IDA
|
-0.785x |
Annual Cash Flow Conversion Efficiency for EUDA Health Holdings Limited (2020–2024)
The table below shows the annual cash flow conversion efficiency of EUDA Health Holdings Limited from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see EUDA Health Holdings Limited market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-2.57 Million | $-2.03 Million | 0.791x | +102.85% |
| 2023-12-31 | $-7.48 Million | $-2.92 Million | 0.390x | -10.42% |
| 2022-12-31 | $-3.51 Million | $-1.53 Million | 0.435x | -41.15% |
| 2021-12-31 | $600.05K | $443.92K | 0.740x | -43.00% |
| 2020-12-31 | $-317.36K | $-411.88K | 1.298x | -- |
About EUDA Health Holdings Limited
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.